Credit: Mary Ann Liebert, Inc., publishers
New Rochelle, NY, February 9, 2021 The rapid upscaling of a telemonitoring program in which health care providers performed daily telemedicine check-ins on COVID-19 patients faced a unique set of challenges. How these were resolved, and early outcomes are reported in the peer-reviewed journal
Telemedicine and e-Health, Click here to read the article now. Kaiser Permanente s Virtual Home Care Program (VHCP) was able to rapidly establish a telemedicine-based program for the management of COVID-19 positive patients in the DC and Baltimore Metro regions. Preliminary data suggest that such a program may be effective in keeping patients out of the hospital and/or emergency room, stated James Shaw, MD, Med-Atlantic Permanente Medical Group, and coauthors.
(Stock image courtesy of Metro Creative)
MARQUETTE A new partnership agreement between Grand Valley State University and Northern Michigan University creates a pipeline for NMU undergraduates to GVSU’s public health graduate program.
The articulation agreement, developed by GVSU’s Department of Public Health and NMU’s School of Health and Human Performance, allows Grand Valley to recruit and directly admit up to five students from NMU’s community health programs to Grand Valley’s Master of Public Health Program.
Ranelle Brew, chair of the Department of Public Health at Grand Valley and director of the Master of Public Health Program, said overall, there is a shortage of public health professionals in northern Michigan and the Upper Peninsula.
2020 in review: COVID-19 was the story
December 21, 2020
The first mention of the word “coronavirus” in a Cornell Chronicle story in 2020 came on Jan. 29, when the university designated mainland China as an elevated-risk destination, and imposed travel restrictions on students, faculty and staff.
Since then, there have been more than 300 stories or university statements that mention COVID-19 posted on news.cornell.edu. It has been the story of the year.
The most-read Chronicle story of the year was a Weill Cornell Medicine-produced research FAQ from April 20, “Why is COVID-19 mild for some, deadly for others?” Given the fact that so much remains unknown about this mysterious virus, it’s no surprise that more than 60,000 readers – and counting – clicked on this story.
All your COVID-19 vaccine questions answered
In anticipation of pivotal vaccine decisions that will be made by the Food and Drug Administration this week, Northeastern faculty from the Bouvé College of Health Sciences discussed the most pressing vaccine questions during a Facebook Live panel on Wednesday. Screenshot by Northeastern University
By Emily Arntsen
News at Northeastern
When can I get a vaccine? How does it work? And will I still need to wear a mask afterward?
These are some of the many questions people have in advance of the Food and Drug Administration’s open committee meeting on Thursday, when the agency is expected to make the final decisions regarding